T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapyGuido Ghilardi, Marco Ruella, Joseph A. Fraietta et al.|Nature Medicine|2024Cited by 254
Genomic Signatures Predict the Immunogenicity of BRCA-Deficient Breast CancerAdam Kraya, Katherine L. Nathanson, Kara N. Maxwell et al.|Clinical Cancer Research|2019Cited by 103
Clinical Utility of Next-Generation Sequencing for Oncogenic Mutations in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell TransplantationMarlise R. Luskin, Ran Reshef, Martin Carroll et al.|Biology of Blood and Marrow Transplantation|2016Cited by 38
NPM1 mutation is associated with leukemia cutis in acute myeloid leukemia with monocytic featuresMarlise R. Luskin, Alexander E. Perl, Seth A. Brooks et al.|Haematologica|2015Cited by 34
Mutational Shift in FLT3 and NPM1-Positive Acute Myeloid Leukemia (AML) Relative to Therapy and Disease ProgressionPriya Velu, Selina M. Luger, Chris C.‐S. Hsiung et al.|Blood|2016Cited by 0